James O’Neill, MD
Texas Heart Institute Positions
- Fellow, Interventional Cardiology Fellowship
Education
-
Medical School:
Baylor College of Medicine
-
Residency:
Washington University Barnes Jewish Hospital
Publications
4862227
CCKXEPZV
1
alternatives-to-animal-experimentation
10
date
desc
O'Neill
2033
https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22BD53AN2A%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Topkara%20et%20al.%22%2C%22parsedDate%22%3A%222014-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BTopkara%2C%20V.%20K.%2C%20O%26%23x2019%3BNeill%2C%20J.%20K.%2C%20Carlisle%2C%20A.%20et%20al.%20%282014%29.%20HeartWare%20and%20HeartMate%20II%20left%20ventricular%20assist%20devices%20as%20bridge%20to%20transplantation%3A%20a%20comparative%20analysis.%20%26lt%3Bi%26gt%3BAnn%20Thorac%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B97%26lt%3B%5C%2Fi%26gt%3B%2C%20506%26%23x2013%3B512.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.athoracsur.2013.08.048%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.athoracsur.2013.08.048%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HeartWare%20and%20HeartMate%20II%20left%20ventricular%20assist%20devices%20as%20bridge%20to%20transplantation%3A%20a%20comparative%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veli%20K.%22%2C%22lastName%22%3A%22Topkara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20K.%22%2C%22lastName%22%3A%22O%27Neill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Carlisle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Novak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20C.%22%2C%22lastName%22%3A%22Silvestry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20A.%22%2C%22lastName%22%3A%22Ewald%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20purpose%20of%20this%20study%20is%20to%20comparatively%20analyze%20outcomes%20of%20heart%20transplant%20patients%20bridged%20to%20transplantation%20with%20HeartWare%20%28HW-VAD%29%20versus%20HeartMate%20II%20%28HMII-VAD%29%20left%20ventricular%20assist%20devices.%5CnMETHODS%3A%20The%20United%20Network%20for%20Organ%20Sharing%20Database%20was%20reviewed%20to%20identify%20first-time%20heart%20transplant%20recipients%20who%20were%20bridged%20to%20transplantation%20with%20either%20HW-VAD%20%28n%3D141%29%20or%20HMII-VAD%20%28n%3D1824%29%20from%20January%202009%20through%20July%202012.%5CnRESULTS%3A%20Recipients%20of%20HW-VAD%20had%20a%20higher%20proportion%20of%20female%20patients%20%2827.0%25%20versus%2018.9%25%3B%20p%3D0.019%29%2C%20a%20lower%20body%20surface%20area%20%282.01%5Cu00b10.25%20m2%20versus%202.06%5Cu00b10.25%20m2%3B%20p%3D0.035%29%2C%20and%20a%20trend%20toward%20a%20higher%20peak%20percentage%20of%20panel%20reactive%20antibody%20against%20human%20leukocyte%20class%20I%20antigens%20%2840.4%25%5Cu00b132.8%25%20versus%2033.0%25%5Cu00b130.4%25%3B%20p%3D0.070%29.%20Pretransplantation%20recipient%20cardiac%20index%20%282.33%5Cu00b10.66%20L%5Cu22c5min%28-1%29%5Cu22c5m%28-2%29%20versus%202.33%5Cu00b10.68%20L%5Cu22c5min%28-1%29%5Cu22c5m%28-2%29%29%2C%20serum%20creatinine%20%281.21%5Cu00b10.43%20mg%5C%2FdL%20versus%201.26%5Cu00b10.57%20mg%5C%2FdL%29%2C%20and%20total%20bilirubin%20%281.34%5Cu00b13.45%20mg%5C%2FdL%20versus%201.06%5Cu00b11.84%20mg%5C%2FdL%29%20were%20comparable%20between%20the%20two%20groups%20%28p%26gt%3B0.05%20for%20all%20comparisons%29.%20After%20transplantation%2C%20there%20were%20no%20significant%20differences%20in%20freedom%20from%20rejection%20or%20freedom%20from%20cardiac%20allograft%20vasculopathy.%20Posttransplant%20graft%20survival%20rates%20were%20similar%20between%20the%20HW-VAD%20group%20and%20the%20HMII-VAD%20group%20at%201%2C%202%2C%20and%203%20years%20%2888.4%25%20versus%2087.8%25%2C%2079.9%25%20versus%2083.8%25%2C%20and%2077.4%25%20versus%2079.9%25%2C%20respectively%3B%20p%3D0.843%29.%5CnCONCLUSIONS%3A%20These%20findings%20suggest%20similar%20hemodynamic%20unloading%2C%20pretransplant%20end-organ%20function%2C%20and%20posttransplant%20outcomes%20in%20patients%20bridged%20to%20transplantation%20with%20both%20the%20HW-VAD%20and%20HMII-VAD.%22%2C%22date%22%3A%22Feb%202014%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.athoracsur.2013.08.048%22%2C%22ISSN%22%3A%221552-6259%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22CCKXEPZV%22%5D%2C%22dateModified%22%3A%222018-05-21T21%3A15%3A35Z%22%7D%7D%5D%7D
Topkara, V. K., O’Neill, J. K., Carlisle, A. et al. (2014). HeartWare and HeartMate II left ventricular assist devices as bridge to transplantation: a comparative analysis. Ann Thorac Surg 97, 506–512. https://doi.org/10.1016/j.athoracsur.2013.08.048.
